NCT02020252 Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials Status COMPLETED Phase N/A
NCT02020213 Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection. Status WITHDRAWN Phase PHASE4
NCT02015910 Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers Status TERMINATED Phase PHASE4
NCT02014636 Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018) Status COMPLETED Phase PHASE1
NCT02013154 A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Status COMPLETED Phase PHASE1
NCT02012166 A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) Status COMPLETED Phase PHASE1
NCT02011490 Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105) Status COMPLETED Phase PHASE1
NCT02011386 Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis Status COMPLETED Phase N/A
NCT02009345 Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada Status RECRUITING Phase N/A
NCT02007070 Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025) Status COMPLETED Phase PHASE1
NCT02004886 A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005) Status COMPLETED Phase PHASE2
NCT02003508 Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination Status COMPLETED Phase N/A
NCT02001818 Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia Status COMPLETED Phase PHASE2
NCT02000622 Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. Status COMPLETED Phase PHASE3
NCT01999218 Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002) Status COMPLETED Phase PHASE3
NCT01998737 Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX Status COMPLETED Phase N/A
NCT01998269 A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS) Status COMPLETED Phase N/A
NCT01995721 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children Status UNKNOWN Phase PHASE3
NCT01986881 Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004) Status COMPLETED Phase PHASE3